Search the Newsreel

Equity in earnings of VSee Health, Inc. – OTC:VSEE

The article reports on the equity in earnings of VSee Health, Inc. (OTC:VSEE). It provides an overview of the company's financial data as available on TradingView. The content is primarily a listing of navigation and footer elements typical of a financial data platform.

VSee Health, Inc. Balance Sheet – OTC:VSEE

VSee Health, Inc. (OTC:VSEE) reported its Q1 2026 financial position, showing total assets at $19.02 million, a 15.15% decrease from Q4 2025. Total liabilities also decreased by 25.15% to $12.70 million in the same quarter. The report provides a snapshot of the company's balance …

Return on assets % of VSEE HEALTH INC – OTC:VSEE

This article provides financial data for VSee Health, Inc. (OTC:VSEE), specifically focusing on its return on assets percentage. It indicates the stock's market status as closed with no recent trades, and presents information about its financial overview on the TradingView platform.

CVS Q2 Earnings Call Pairs Aetna Recovery With 2027 PBM Risks

CVS Health Corporation CVS used its Q2 2026 earnings call to pair stronger 2026 expectations with an early warning about pharmacy-services pressure next year. Management emphasized Aetna's recovery and retail execution. Adjusted EPS of $2.58 topped the Zacks Consensus Estimate of $1.87, while revenues …

VSE Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:VSEC) 2026-08-06

Is VSE (VSEC) Still Below Fair Value As Strong Q2 Results Lift Guidance?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. VSE lifts guidance after Q2 earnings beat expectations VSE (VSEC) drew fresh attention after reporting second quarter 2026 results that topped market expectations …

VSee Health Faces Nasdaq Trading Suspension and Delisting

VSee Health is facing suspension and delisting from Nasdaq due to its stock consistently trading below $1.00 and recently falling to $0.10 or less for ten consecutive days. The company, which previously received a 180-day grace period, may request a hearing but cautions that …

Why Is VSE (VSEC) In Focus After Its Strong Q2 2026 Earnings Beat?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. VSE Corporation (NasdaqGS: VSEC) reported Q2 2026 results with substantial year over year revenue and earnings growth. The company delivered an earnings outcome that …

VSE Corporation earnings beat by $0.82, revenue topped estimates

VSE Corporation (NASDAQ: VSEC) reported strong second-quarter results, beating analyst estimates for both earnings per share (EPS) and revenue. The company posted an EPS of $1.75, significantly higher than the estimated $0.93, and revenue of $449.1 million, exceeding the consensus of $427.57 million. VSE's …

William Blair Maintains VSE Corp(VSEC.US) With Buy Rating

William Blair has reaffirmed its Buy rating for VSE Corp (VSEC.US). This indicates a continued positive outlook from the firm regarding VSE Corp's stock performance.

VSE Corporation (NASDAQ:VSEC) Delivers Impressive Q2 CY2026

VSE Corporation (NASDAQ:VSEC) Delivers Impressive Q2 CY2026 Aviation and fleet aftermarket services provider VSE Corporation (NASDAQ:VSEC) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 65% year on year to $449.1 million. Its non-GAAP profit of $1.75 per share was …

VSE Corporation (NASDAQ: VSEC) doubles profit and raises 2026 outlook

VSE Corporation reported strong Q2 2026 results, with revenue growing 65% to $449.1 million and GAAP net income doubling to $28.5 million, driven by significant acquisitions and organic growth. The company also announced a record Adjusted EBITDA of $86.0 million and raised its full-year …

VSE Corporation Announces Second Quarter 2026 Results

Record Revenue and Profitability Raises 2026 Guidance MIRAMAR, Fla., August 05, 2026--(BUSINESS WIRE)--VSE Corporation ("VSE" or the "Company") (NASDAQ: VSEC, VSECU), a leading provider of aviation aftermarket distribution and repair services, announced today results for the second quarter 2026. SECOND QUARTER 2026 RESULTS(1) (As …

LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs

Eli Lilly (LLY) stock extended gains on Wednesday after the pharmaceutical behemoth announced a new direct-to-consumer (DTC) collaboration with CVS Health (CVS). The press release said this team-up aims to improve patient access, affordability, and pharmacy support for Eli Lilly's blockbuster weight-loss treatments, Zepbound …

CVS Health Corp (CVS) (Q2 2026) Earnings Call Highlights: Strong Earnings Beat and Raised ...

This article first appeared on GuruFocus. Revenue: Over $106 billion in Q2 2026, an increase of over 7% year-over-year. Adjusted Operating Income: Approximately $5.2 billion, up 35% from the prior year quarter. Adjusted EPS: $2.58, a significant increase of over 40% year-over-year. Cash Flow …

CVS Stock Drops 5.8% as 2027 Outlook Disappoints

This article first appeared on GuruFocus. CVS Health (NYSE:CVS), a healthcare giant spanning insurance, pharmacy-benefit management and retail pharmacies, delivered another strong quarter on Wednesday, but Wall Street still hit the sell button as the stock fell 5.8% in regular trading. Adjusted earnings jumped …

CVS Health Corp Stock (CVS) Moved Down by 4.65% on Aug 5: Drivers Behind the Movement

CVS Health (CVS) stock declined by 4.65% on August 5th, primarily due to increased medical benefit ratios in its insurance division and a lowered full-year earnings guidance. The company faces ongoing challenges from elevated medical utilization rates, soft consumer spending, and reimbursement headwinds in …

CVS Health Corporation Q2 2026 Earnings Call Summary

CVS Health Corporation Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Delivered …

CVS Health Corp. stock underperforms Wednesday when compared to competitors

CVS Health Corp. (CVS) stock fell by 5.08% on Wednesday, closing at $99.12. This underperformance occurred on a mixed trading day, with the Dow Jones Industrial Average rising but the S&P 500 Index declining. This marks the second consecutive day of losses for CVS …

CVS forecasts at least $11.5B in 2026 operating cash flow as it raises adjusted EPS guidance to $7.90-$8.10

Earnings Call Insights: CVS Health (CVS) Q2 2026 MANAGEMENT VIEW * "This quarter, each of our operating segments grew earnings and delivered performance that exceeded our expectations," said (CEO, President & Chairman J. Joyner), adding, "We generated adjusted operating income of $5.2 billion and …

CVS Health Stock Is Falling Wednesday: What's Going On? - CVS Health (NYSE:CVS)

CVS Health stock experienced a significant drop on Wednesday despite reporting strong second-quarter earnings that surpassed analyst expectations and raising its full-year guidance. The decline is attributed to profit-taking after a substantial rally, and the company also announced an expanded GLP-1 weight management platform …

CVS Health tops second-quarter estimates, raises full-year profit outlook

CVS Health tops second-quarter estimates, raises full-year profit outlook Proactive uses images sourced from Shutterstock CVS Health Corp (NYSE:CVS) reported second-quarter revenue and profit that beat Wall Street estimates on Wednesday, and raised its full-year adjusted earnings guidance, though cautious guidance pressured shares. Revenue …

CVS Health (CVS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

CVS Health (CVS) reported $106.1 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 7.3%. EPS of $2.58 for the same period compares to $1.81 a year ago. The reported revenue represents a surprise of +5.91% over the Zacks …

Earnings Call: CVS Health übertrifft Prognosen für Q2 2026, Aktie fällt aber vorbörslich

(RTTNews) - CVS Health Corp. (CVS) will host a conference call at 8:00 AM ET on August 5, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.cvshealth.com/events-and-presentations/default.aspx The views and opinions expressed herein are the views and …

VSEC Stock Price and Chart — NASDAQ:VSEC

This article provides a comprehensive overview of VSE Corporation (VSEC) stock, including its current price, historical performance, key financial statistics, and analyst ratings. It details the company's recent earnings report, highlighting record revenue and profitability driven by strong organic growth and acquisitions in the …

CVS Health Corp earnings beat by $0.75, revenue topped estimates

CVS Health Corp (NYSE: CVS) reported strong second-quarter results, with EPS of $2.58, significantly beating the analyst estimate of $1.83. Revenue also surpassed expectations, reaching $106.1 billion against a consensus of $100.03 billion. The company provided a positive full-year 2026 EPS guidance of $7.90-$8.10, …

CVS Health Q2 26 Earnings Conference Call At 8:00 AM ET

(RTTNews) - CVS Health Corp. (CVS) will host a conference call at 8:00 AM ET on August 5, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.cvshealth.com/events-and-presentations/default.aspx The views and opinions expressed herein are the views and …

CVS Health (NYSE:CVS) Reports Bullish Q2 CY2026

CVS Health (NYSE:CVS) Reports Bullish Q2 CY2026 Diversified healthcare company CVS Health (NYSE:CVS) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 7.3% year on year to $106.1 billion. Its non-GAAP profit of $2.58 per share was 39.4% above analysts' …

CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year Second quarter GAAP diluted EPS of $2.31 and Adjusted EPS of $2.58 Generated year-to-date cash flow from operations of $10.6 billion Raising full-year 2026 guidance: GAAP diluted EPS guidance range to $6.84 to …

VSee Health, Inc.(OTCPK: VSEE) dropped from NASDAQ Composite Index

VSee Health, Inc. (OTCPK:VSEE) has been removed from the NASDAQ Composite Index as of August 4, 2026. This news follows several recent developments for the company, including signing a letter of intent to acquire certain healthcare technology assets for $42 million and initiating a …

VSee Health Received Notice of Delisting

VSee Health received a delisting notice from Nasdaq on July 30, 2026, because its closing bid price fell below $0.10 for ten consecutive trading days. Trading of its securities will be suspended on August 6, 2026, and a Form 25-NSE will be filed. The …

CVS Health earns two Gold and one Silver Stevie® Awards for Great Employers

AI Learning Academy honored for building enterprise-wide AI literacy and colleague confidence WOONSOCKET, R.I., Aug. 4, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that its AI Learning Academy earned two Golds and one Silver at the 11th Annual Stevie Awards for Great …

Kyivstar Opens New York Office to Strengthen Investor Relations and Global Business Presence

Kyivstar Group, the parent company of Ukraine's leading electronic communications operator, has opened an office in Rockefeller Center, New York. This move follows its Nasdaq listing in August 2025, making it the first Ukrainian company on the US stock exchange, and aims to bolster …

Barclays Maintains Kyivstar Group(KYIV.US) With Buy Rating, Maintains Target Price $15

Barclays has reiterated its Buy rating for Kyivstar Group (KYIV.US) and maintained its target price at $15. This indicates continued confidence from the firm in the company's performance and future prospects.

ETFs Investing in VSE Corporation Stocks

This article lists various Exchange Traded Funds (ETFs) that hold VSE Corporation stocks, providing key metrics for each fund. The data includes market value, weight, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year NAV total …

VSE Corporation Earnings: What To Look For From VSEC